Research graph
References from Triple Preventive Therapy with OnabotulinumtoxinA, Fremanezumab, and Atogepant in Treatment-Resistant Chronic Migraine: A 52-Week Pilot Case Series (TRIPLE Cohort). Local targets link to admitted publications; unresolved targets remain external evidence.
10.1056/nejmra1915327
10.1056/nejmra1915327 · 2020 · External reference
10.1016/s1474-4422(25)00402-8
10.1016/s1474-4422(25)00402-8 · External reference
10.1038/s41582-024-01002-5
10.1038/s41582-024-01002-5 · 2024 · External reference
10.1016/s0140-6736(25)00109-6
10.1016/s0140-6736(25)00109-6 · 2025 · External reference
10.1186/s10194-024-01925-w
10.1186/s10194-024-01925-w · 2024 · External reference
10.1007/s00415-023-11706-1
10.1007/s00415-023-11706-1 · 2023 · External reference
10.1111/head.70114
10.1111/head.70114 · 2026 · External reference
Unresolved reference
2024 · External reference
10.1212/wnl.0000000000214659
10.1212/wnl.0000000000214659 · 2026 · External reference
10.1177/03331024241273968
10.1177/03331024241273968 · 2024 · External reference
10.1111/ene.15816
10.1111/ene.15816 · 2023 · External reference
10.1007/s40120-023-00529-x
10.1007/s40120-023-00529-x · 2023 · External reference
10.1177/03331024251320608
10.1177/03331024251320608 · 2025 · External reference
10.1080/15360288.2020.1829249
10.1080/15360288.2020.1829249 · 2021 · External reference
10.1007/s40122-021-00264-x
10.1007/s40122-021-00264-x · 2021 · External reference
10.1007/s40122-024-00649-8
10.1007/s40122-024-00649-8 · 2024 · External reference
10.1177/03331024251398011
10.1177/03331024251398011 · 2025 · External reference
10.1186/s10194-024-01783-6
10.1186/s10194-024-01783-6 · 2024 · External reference
10.3389/fneur.2021.788159
10.3389/fneur.2021.788159 · 2021 · External reference
10.1177/03331024261429118
10.1177/03331024261429118 · 2026 · External reference
10.3389/fneur.2021.656294
10.3389/fneur.2021.656294 · 2021 · External reference
10.1111/head.14244
10.1111/head.14244 · 2022 · External reference
10.1007/s40120-024-00586-w
10.1007/s40120-024-00586-w · 2024 · External reference
10.1111/head.13930
10.1111/head.13930 · 2020 · External reference
10.1111/head.14954
10.1111/head.14954 · 2025 · External reference
10.1007/s40120-023-00556-8
10.1007/s40120-023-00556-8 · 2024 · External reference
10.1111/head.14095
10.1111/head.14095 · 2021 · External reference
10.1186/s10194-020-01130-5
10.1186/s10194-020-01130-5 · 2020 · External reference
10.1016/s0022-3999(01)00296-3
10.1016/s0022-3999(01)00296-3 · External reference
10.1016/j.jmpt.2003.11.003
10.1016/j.jmpt.2003.11.003 · 2004 · External reference
10.1177/03331024211042385
10.1177/03331024211042385 · 2022 · External reference
10.1186/s10194-022-01393-0
10.1186/s10194-022-01393-0 · 2022 · External reference
10.1111/head.13654
10.1111/head.13654 · 2019 · External reference
10.1016/j.ebiom.2023.104943
10.1016/j.ebiom.2023.104943 · 2024 · External reference
10.1007/s00415-023-12103-4
10.1007/s00415-023-12103-4 · 2024 · External reference
10.1212/wnl.0000000000207292
10.1212/wnl.0000000000207292 · 2023 · External reference
10.1177/0333102414527648
10.1177/0333102414527648 · 2014 · External reference
10.1523/jneurosci.0576-17.2017
10.1523/jneurosci.0576-17.2017 · 2017 · External reference
10.1523/jneurosci.2211-17.2017
10.1523/jneurosci.2211-17.2017 · 2017 · External reference
10.1177/0333102416636843
10.1177/0333102416636843 · 2016 · External reference
10.1177/0333102419873675
10.1177/0333102419873675 · 2019 · External reference
10.1177/03331024221083544
10.1177/03331024221083544 · 2022 · External reference
10.1111/head.14903
10.1111/head.14903 · 2025 · External reference
10.1097/wco.0000000000000932
10.1097/wco.0000000000000932 · 2021 · External reference
10.3390/pharmaceutics12121180
10.3390/pharmaceutics12121180 · 2020 · External reference
10.1111/head.14153
10.1111/head.14153 · 2021 · External reference
10.1002/ana.25831
10.1002/ana.25831 · 2020 · External reference
10.1177/03331024231152169
10.1177/03331024231152169 · 2023 · External reference
